In this study, we exploited a cyclic peptide with high affinity with PDGFR-β as a targeting moiety to establish a dual-targeting drug delivery system that could not only improve the cellular uptake of CNPs by myeloma cells and CAFs but also induce more cell apoptosis of both types of cells when PTX was loaded. Here, PDGFRB is linked to plasma cell myeloma.